W. Fong

发表

SARS-CoV-2 Within-Host and in vitro Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and in vitro Culture

V. Sintchenko, C. Lam, J. Kok, 2022, Frontiers in Microbiology.

SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples

V. Sintchenko, C. Lam, J. Kok, 2021, Journal of clinical microbiology.

Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance

E. Holmes, V. Sintchenko, D. Dwyer, 2022, Nature Communications.

Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance

V. Sintchenko, V. Timms, Eby M. Sim, 2022, The Journal of antimicrobial chemotherapy.

Detection and characterisation of Bordetella hinzii in line-related bacteraemia and respiratory tract infection in Australia.

V. Sintchenko, A. Polkinghorne, M. Gall, 2022, Pathology.

Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine

V. Sintchenko, C. Lam, D. Dwyer, 2022, Viruses.

Improved neutralization of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting

V. Sintchenko, C. Lam, D. Dwyer, 2021 .

RESISTANCE CONFERRING MUTATIONS IN SARS-CoV-2 DELTA FOLLOWING SOTROVIMAB INFUSION

V. Sintchenko, D. Dwyer, J. Kok, 2021, medRxiv.

Genomic evaluation of Bordetella spp. originating from Australia

V. Sintchenko, V. Timms, Eby M. Sim, 2021, bioRxiv.

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use

V. Sintchenko, D. Dwyer, J. Kok, 2022, The New England journal of medicine.

Optimization of sample preparation for culture-independent sequencing of Bordetella pertussis

V. Sintchenko, R. Rockett, V. Timms, 2020, Microbial genomics.

SARS-CoV-2 within-host and in-vitro genomic variability and sub-genomic RNA levels indicate differences in viral expression between clinical and in-vitro cohorts.

V. Sintchenko, C. Lam, J. Kok, 2021, medRxiv.

Improved neutralisation of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech (BNT162b2) COVID-19 vaccine boosting with a third dose

V. Sintchenko, C. Lam, M. O’Sullivan, 2021, bioRxiv.

Detection and incidence of Bordetella holmesii in respiratory specimens from patients with pertussis-like symptoms in New South Wales, Australia.

V. Sintchenko, N. Holmes, V. Timms, 2018, Pathology.

Evaluation of the BioGX BD-Max PCR assay for detection of pathogenic Bordetella.

V. Sintchenko, N. Jeoffreys, V. Timms, 2019, Pathology.

Comparison of library preparation and sequencing depths for direct sequencing of Bordetella pertussis positive samples

V. Sintchenko, R. Sadsad, R. Rockett, 2021, bioRxiv.

A laboratory framework for ongoing optimisation of amplification based genomic surveillance programs

V. Sintchenko, C. Lam, C. Suster, 2023, bioRxiv.

Improved neutralisation of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech (BNT162b2) COVID-19 vaccine boosting with a third dose

V. Sintchenko, Dominic Michael Dwyer, C. Lam, 2021, bioRxiv.

Genomic evolution of SARS-CoV-2 variants of concern under in vitro neutralising selection pressure following two doses of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine

V. Sintchenko, C. Lam, R. Rockett, 2023, bioRxiv.